The first American volunteer will be vaccinated with an experimental vaccine against the coronavirus on Monday, which means sometime tonight until tomorrow morning Vietnam time.

The trial, sponsored by the US National Institutes of Health (NIH), will take place at the Kaiser Permanente Washington Medical Research Institute in Seattle.

Previously, developing a vaccine for a disease often took many years to decades.

The NIH vaccine was scheduled for testing in April but is now half a month ahead of schedule.

According to the Associated Press, the first vaccine trial against the SARS-CoV-2 virus strain that is causing the Covid-19 epidemic in the US will be conducted with 45 young volunteers in good health.

Each group of volunteers will receive different doses of the vaccine to evaluate its potential side effects.

Amid the Covid-19 pandemic that has infected more than 169,000 people, in more than 100 countries and territories, killing more than 6,000 of them, dozens of research groups around the world are racing to produce

Last month, a research team at the University of Queensland in Australia announced they had developed a potential vaccine for Covid-19 and had begun testing it in animals.

Professor Paul Young, head of the School of Chemistry and Molecular Biology at the University of Queensland, said his research team had a total of 20 people.

There are currently multiple vaccines targeting the coronavirus, with different strategies.

In addition to Moderna’s vaccine, which will begin testing today, Inovio, an American pharmaceutical company, said it will also launch human trials of its vaccine against the SARS-CoV-2 virus.

A few dozen volunteers at the University of Pennsylvania and a testing center in Kansas City, Missouri will receive the vaccine.

`Even if these initial safety trials go well, you’d still need a year to a year and a half before any vaccine would be ready for widespread use,` Dr.

But that would still be a record pace.

The safety trials are the first to be conducted in phase I clinical trials, aimed at monitoring possible side effects of the potential vaccine.

Next-stage efficacy trials typically aim to vaccinate a few hundred to a few thousand healthy volunteers in endemic areas where the pathogen is highly endemic to see how much protection the vaccine can provide.

If the results of this trial are good, the manufacturer can apply for a license to supply its vaccine to the market.

So the time between when researchers discover a potential vaccine and when it completes all stages of testing will last at least a year.

In fact, at this time, Covid-19 is still considered a disease with no specific treatment.

A drug called remdesivir is also being tested against SARS-CoV-2.

The drug remdesivir is currently being tested on humans at the University of Nebraska Medical Center.

For most people, the new coronavirus causes only mild or moderate symptoms, such as fever and cough.

But for others, especially older adults and people with underlying health conditions such as diabetes, cancer, and cardiovascular disease, Covid-19 can be a truly dangerous disease, because the virus will

The death rate of Covid-19 is 10 times higher than seasonal flu, at about 1-3% depending on the region.

*To better understand the new coronavirus that is causing the Covid-19 pandemic, let’s take the quiz below:

References AP, Independent